Why iSpecimen Shares Are Gaining Today?

iSpecimen Inc  (NASDAQ: ISPC ) has added new global biospecimen suppliers  to its proprietary Marketplace platform for advancing oncology and cardiovascular disease research. The new suppliers include a cancer-focused biobank in the U.S., which contains a differentiated range of pre-and post-treatment tissue and ... Full story available on Benzinga.com